GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Gate AG (XTER:BIG1) » Definitions » Forward PE Ratio

Bio-Gate AG (XTER:BIG1) Forward PE Ratio : 0.00 (As of Jun. 19, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Bio-Gate AG Forward PE Ratio?

Bio-Gate AG's Forward PE Ratio for today is 0.00.

Bio-Gate AG's PE Ratio without NRI for today is 0.00.

Bio-Gate AG's PE Ratio for today is 0.00.


Bio-Gate AG Forward PE Ratio Historical Data

The historical data trend for Bio-Gate AG's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Gate AG Forward PE Ratio Chart

Bio-Gate AG Annual Data
Trend
Forward PE Ratio

Bio-Gate AG Semi-Annual Data
Forward PE Ratio

Competitive Comparison of Bio-Gate AG's Forward PE Ratio

For the Medical Instruments & Supplies subindustry, Bio-Gate AG's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Gate AG's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Gate AG's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Bio-Gate AG's Forward PE Ratio falls into.



Bio-Gate AG Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Bio-Gate AG  (XTER:BIG1) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Bio-Gate AG Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Bio-Gate AG's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Gate AG (XTER:BIG1) Business Description

Traded in Other Exchanges
Address
Neumeyerstraße 28-34, Nürnberg, DEU
Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.
Executives
Karl Richter Supervisory Board

Bio-Gate AG (XTER:BIG1) Headlines

No Headlines